nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—prostate cancer—testicular cancer	0.503	1	CtDrD
Cabazitaxel—TUBB2B—Vinblastine—testicular cancer	0.0374	0.0928	CbGbCtD
Cabazitaxel—TUBB6—Vinblastine—testicular cancer	0.0374	0.0928	CbGbCtD
Cabazitaxel—TUBB3—Vinblastine—testicular cancer	0.0374	0.0928	CbGbCtD
Cabazitaxel—TUBB4A—Vinblastine—testicular cancer	0.0374	0.0928	CbGbCtD
Cabazitaxel—TUBB2A—Vinblastine—testicular cancer	0.0374	0.0928	CbGbCtD
Cabazitaxel—TUBB8—Vinblastine—testicular cancer	0.0374	0.0928	CbGbCtD
Cabazitaxel—TUBB4B—Vinblastine—testicular cancer	0.0313	0.0776	CbGbCtD
Cabazitaxel—TUBB1—Vinblastine—testicular cancer	0.0313	0.0776	CbGbCtD
Cabazitaxel—TUBB—Vinblastine—testicular cancer	0.0313	0.0776	CbGbCtD
Cabazitaxel—ABCG2—Dactinomycin—testicular cancer	0.00987	0.0245	CbGbCtD
Cabazitaxel—SLCO1B3—Methotrexate—testicular cancer	0.00795	0.0197	CbGbCtD
Cabazitaxel—ABCG2—Carboplatin—testicular cancer	0.00663	0.0164	CbGbCtD
Cabazitaxel—CYP3A5—Ifosfamide—testicular cancer	0.00646	0.016	CbGbCtD
Cabazitaxel—CYP2C8—Ifosfamide—testicular cancer	0.00621	0.0154	CbGbCtD
Cabazitaxel—ABCG2—Cisplatin—testicular cancer	0.00567	0.014	CbGbCtD
Cabazitaxel—ABCG2—Etoposide—testicular cancer	0.00557	0.0138	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—testicular cancer	0.00463	0.0115	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—testicular cancer	0.0038	0.00941	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—testicular cancer	0.00368	0.00912	CbGbCtD
Cabazitaxel—ABCB1—Dactinomycin—testicular cancer	0.00356	0.00882	CbGbCtD
Cabazitaxel—CYP3A5—Etoposide—testicular cancer	0.00308	0.00765	CbGbCtD
Cabazitaxel—CYP2C8—Etoposide—testicular cancer	0.00297	0.00735	CbGbCtD
Cabazitaxel—CYP3A4—Ifosfamide—testicular cancer	0.00252	0.00624	CbGbCtD
Cabazitaxel—ABCB1—Vinblastine—testicular cancer	0.00223	0.00552	CbGbCtD
Cabazitaxel—ABCB1—Cisplatin—testicular cancer	0.00204	0.00506	CbGbCtD
Cabazitaxel—ABCB1—Etoposide—testicular cancer	0.00201	0.00498	CbGbCtD
Cabazitaxel—ABCB1—Doxorubicin—testicular cancer	0.00137	0.00339	CbGbCtD
Cabazitaxel—CYP3A4—Vinblastine—testicular cancer	0.00134	0.00331	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—testicular cancer	0.00133	0.00329	CbGbCtD
Cabazitaxel—CYP3A4—Etoposide—testicular cancer	0.0012	0.00298	CbGbCtD
Cabazitaxel—TUBB8—testis—testicular cancer	0.000997	0.047	CbGeAlD
Cabazitaxel—TUBA4A—seminal vesicle—testicular cancer	0.000992	0.0468	CbGeAlD
Cabazitaxel—TUBB4A—embryo—testicular cancer	0.000847	0.0399	CbGeAlD
Cabazitaxel—CYP3A4—Doxorubicin—testicular cancer	0.00082	0.00203	CbGbCtD
Cabazitaxel—TUBB2B—seminal vesicle—testicular cancer	0.000769	0.0362	CbGeAlD
Cabazitaxel—TUBB—seminal vesicle—testicular cancer	0.000727	0.0343	CbGeAlD
Cabazitaxel—TUBB2A—seminal vesicle—testicular cancer	0.000723	0.0341	CbGeAlD
Cabazitaxel—TUBA4A—gonad—testicular cancer	0.000717	0.0338	CbGeAlD
Cabazitaxel—TUBB6—seminal vesicle—testicular cancer	0.000714	0.0336	CbGeAlD
Cabazitaxel—TUBB3—testis—testicular cancer	0.000681	0.0321	CbGeAlD
Cabazitaxel—TUBB1—testis—testicular cancer	0.000666	0.0314	CbGeAlD
Cabazitaxel—TUBB4B—embryo—testicular cancer	0.00066	0.0311	CbGeAlD
Cabazitaxel—TUBB4B—seminal vesicle—testicular cancer	0.00062	0.0292	CbGeAlD
Cabazitaxel—TUBA4A—female gonad—testicular cancer	0.000583	0.0275	CbGeAlD
Cabazitaxel—TUBB4A—gonad—testicular cancer	0.000575	0.0271	CbGeAlD
Cabazitaxel—TUBB2B—gonad—testicular cancer	0.000555	0.0262	CbGeAlD
Cabazitaxel—TUBA4A—testis—testicular cancer	0.000517	0.0244	CbGeAlD
Cabazitaxel—TUBB6—gonad—testicular cancer	0.000516	0.0243	CbGeAlD
Cabazitaxel—TUBB4A—female gonad—testicular cancer	0.000467	0.022	CbGeAlD
Cabazitaxel—TUBB2B—female gonad—testicular cancer	0.000451	0.0213	CbGeAlD
Cabazitaxel—TUBB4B—gonad—testicular cancer	0.000448	0.0211	CbGeAlD
Cabazitaxel—TUBB—female gonad—testicular cancer	0.000427	0.0201	CbGeAlD
Cabazitaxel—TUBB2A—female gonad—testicular cancer	0.000425	0.02	CbGeAlD
Cabazitaxel—TUBB6—female gonad—testicular cancer	0.000419	0.0198	CbGeAlD
Cabazitaxel—TUBB4A—testis—testicular cancer	0.000414	0.0195	CbGeAlD
Cabazitaxel—TUBB2B—testis—testicular cancer	0.0004	0.0189	CbGeAlD
Cabazitaxel—TUBB—testis—testicular cancer	0.000379	0.0179	CbGeAlD
Cabazitaxel—TUBB2A—testis—testicular cancer	0.000377	0.0178	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—testicular cancer	0.000375	0.0177	CbGeAlD
Cabazitaxel—TUBB6—testis—testicular cancer	0.000372	0.0175	CbGeAlD
Cabazitaxel—ABCG2—seminal vesicle—testicular cancer	0.000366	0.0172	CbGeAlD
Cabazitaxel—TUBB4B—female gonad—testicular cancer	0.000364	0.0172	CbGeAlD
Cabazitaxel—TUBB4B—testis—testicular cancer	0.000323	0.0152	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—testicular cancer	0.0003	0.0142	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—testicular cancer	0.00029	0.0137	CbGeAlD
Cabazitaxel—TUBB—lymph node—testicular cancer	0.000275	0.0129	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—testicular cancer	0.000273	0.0129	CbGeAlD
Cabazitaxel—TUBB6—lymph node—testicular cancer	0.000269	0.0127	CbGeAlD
Cabazitaxel—TUBB4B—lymph node—testicular cancer	0.000234	0.011	CbGeAlD
Cabazitaxel—ABCG2—female gonad—testicular cancer	0.000215	0.0101	CbGeAlD
Cabazitaxel—CYP3A5—female gonad—testicular cancer	0.000199	0.0094	CbGeAlD
Cabazitaxel—CYP2C8—testis—testicular cancer	0.000196	0.00924	CbGeAlD
Cabazitaxel—ABCB1—embryo—testicular cancer	0.000192	0.00905	CbGeAlD
Cabazitaxel—ABCG2—testis—testicular cancer	0.000191	0.00898	CbGeAlD
Cabazitaxel—ABCB1—seminal vesicle—testicular cancer	0.00018	0.0085	CbGeAlD
Cabazitaxel—ABCG2—lymph node—testicular cancer	0.000138	0.00651	CbGeAlD
Cabazitaxel—ABCB1—gonad—testicular cancer	0.00013	0.00614	CbGeAlD
Cabazitaxel—ABCB1—female gonad—testicular cancer	0.000106	0.00499	CbGeAlD
Cabazitaxel—ABCB1—testis—testicular cancer	9.4e-05	0.00443	CbGeAlD
Cabazitaxel—ABCB1—lymph node—testicular cancer	6.81e-05	0.00321	CbGeAlD
Cabazitaxel—Gastritis—Doxorubicin—testicular cancer	6.43e-05	0.000889	CcSEcCtD
Cabazitaxel—Pain—Cisplatin—testicular cancer	6.43e-05	0.000889	CcSEcCtD
Cabazitaxel—Hypersensitivity—Ifosfamide—testicular cancer	6.43e-05	0.000888	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Doxorubicin—testicular cancer	6.41e-05	0.000886	CcSEcCtD
Cabazitaxel—Renal failure—Methotrexate—testicular cancer	6.36e-05	0.000879	CcSEcCtD
Cabazitaxel—Dysuria—Epirubicin—testicular cancer	6.35e-05	0.000878	CcSEcCtD
Cabazitaxel—Neutropenia—Epirubicin—testicular cancer	6.35e-05	0.000878	CcSEcCtD
Cabazitaxel—Abdominal distension—Doxorubicin—testicular cancer	6.33e-05	0.000874	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—testicular cancer	6.31e-05	0.000872	CcSEcCtD
Cabazitaxel—Conjunctivitis—Methotrexate—testicular cancer	6.29e-05	0.000869	CcSEcCtD
Cabazitaxel—Influenza—Doxorubicin—testicular cancer	6.28e-05	0.000868	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—testicular cancer	6.27e-05	0.000867	CcSEcCtD
Cabazitaxel—Asthenia—Ifosfamide—testicular cancer	6.26e-05	0.000865	CcSEcCtD
Cabazitaxel—Feeling abnormal—Cisplatin—testicular cancer	6.2e-05	0.000857	CcSEcCtD
Cabazitaxel—Paraesthesia—Etoposide—testicular cancer	6.19e-05	0.000855	CcSEcCtD
Cabazitaxel—Haematuria—Methotrexate—testicular cancer	6.17e-05	0.000853	CcSEcCtD
Cabazitaxel—Weight decreased—Epirubicin—testicular cancer	6.14e-05	0.000849	CcSEcCtD
Cabazitaxel—Dyspnoea—Etoposide—testicular cancer	6.14e-05	0.000849	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—testicular cancer	6.13e-05	0.000847	CcSEcCtD
Cabazitaxel—Pneumonia—Epirubicin—testicular cancer	6.09e-05	0.000842	CcSEcCtD
Cabazitaxel—Nausea—Bleomycin—testicular cancer	6.06e-05	0.000838	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—testicular cancer	6.05e-05	0.000837	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—testicular cancer	6.05e-05	0.000837	CcSEcCtD
Cabazitaxel—Vomiting—Dactinomycin—testicular cancer	6.05e-05	0.000837	CcSEcCtD
Cabazitaxel—Decreased appetite—Etoposide—testicular cancer	5.99e-05	0.000828	CcSEcCtD
Cabazitaxel—Diarrhoea—Ifosfamide—testicular cancer	5.97e-05	0.000825	CcSEcCtD
Cabazitaxel—Renal failure—Epirubicin—testicular cancer	5.95e-05	0.000823	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Etoposide—testicular cancer	5.95e-05	0.000822	CcSEcCtD
Cabazitaxel—Body temperature increased—Cisplatin—testicular cancer	5.94e-05	0.000822	CcSEcCtD
Cabazitaxel—Fatigue—Etoposide—testicular cancer	5.94e-05	0.000821	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Epirubicin—testicular cancer	5.94e-05	0.00082	CcSEcCtD
Cabazitaxel—Pain—Etoposide—testicular cancer	5.89e-05	0.000814	CcSEcCtD
Cabazitaxel—Constipation—Etoposide—testicular cancer	5.89e-05	0.000814	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—testicular cancer	5.89e-05	0.000814	CcSEcCtD
Cabazitaxel—Urinary tract infection—Epirubicin—testicular cancer	5.89e-05	0.000814	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—testicular cancer	5.88e-05	0.000812	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—testicular cancer	5.88e-05	0.000812	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—testicular cancer	5.84e-05	0.000807	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—testicular cancer	5.8e-05	0.000802	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—testicular cancer	5.77e-05	0.000798	CcSEcCtD
Cabazitaxel—Dizziness—Ifosfamide—testicular cancer	5.77e-05	0.000797	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Methotrexate—testicular cancer	5.74e-05	0.000793	CcSEcCtD
Cabazitaxel—Urethral disorder—Methotrexate—testicular cancer	5.69e-05	0.000787	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—testicular cancer	5.68e-05	0.000786	CcSEcCtD
Cabazitaxel—Feeling abnormal—Etoposide—testicular cancer	5.68e-05	0.000785	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—testicular cancer	5.67e-05	0.000783	CcSEcCtD
Cabazitaxel—Nausea—Dactinomycin—testicular cancer	5.65e-05	0.000782	CcSEcCtD
Cabazitaxel—Pneumonia—Doxorubicin—testicular cancer	5.63e-05	0.000779	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Etoposide—testicular cancer	5.63e-05	0.000779	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—testicular cancer	5.6e-05	0.000774	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—testicular cancer	5.6e-05	0.000774	CcSEcCtD
Cabazitaxel—Vomiting—Ifosfamide—testicular cancer	5.55e-05	0.000767	CcSEcCtD
Cabazitaxel—Hypersensitivity—Cisplatin—testicular cancer	5.54e-05	0.000766	CcSEcCtD
Cabazitaxel—Renal failure—Doxorubicin—testicular cancer	5.51e-05	0.000761	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—testicular cancer	5.49e-05	0.000759	CcSEcCtD
Cabazitaxel—Abdominal pain—Etoposide—testicular cancer	5.45e-05	0.000753	CcSEcCtD
Cabazitaxel—Body temperature increased—Etoposide—testicular cancer	5.45e-05	0.000753	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—testicular cancer	5.45e-05	0.000753	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—testicular cancer	5.45e-05	0.000753	CcSEcCtD
Cabazitaxel—Eye disorder—Methotrexate—testicular cancer	5.43e-05	0.00075	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—testicular cancer	5.42e-05	0.000749	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—testicular cancer	5.41e-05	0.000748	CcSEcCtD
Cabazitaxel—Asthenia—Cisplatin—testicular cancer	5.4e-05	0.000746	CcSEcCtD
Cabazitaxel—Cardiac disorder—Methotrexate—testicular cancer	5.39e-05	0.000745	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—testicular cancer	5.37e-05	0.000742	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—testicular cancer	5.35e-05	0.00074	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—testicular cancer	5.34e-05	0.000738	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—testicular cancer	5.34e-05	0.000738	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—testicular cancer	5.33e-05	0.000736	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—testicular cancer	5.27e-05	0.000728	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—testicular cancer	5.25e-05	0.000725	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—testicular cancer	5.23e-05	0.000724	CcSEcCtD
Cabazitaxel—Chills—Methotrexate—testicular cancer	5.21e-05	0.00072	CcSEcCtD
Cabazitaxel—Nausea—Ifosfamide—testicular cancer	5.18e-05	0.000716	CcSEcCtD
Cabazitaxel—Diarrhoea—Cisplatin—testicular cancer	5.15e-05	0.000711	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—testicular cancer	5.13e-05	0.000709	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—testicular cancer	5.09e-05	0.000703	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—testicular cancer	5.08e-05	0.000702	CcSEcCtD
Cabazitaxel—Hypersensitivity—Etoposide—testicular cancer	5.08e-05	0.000702	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—testicular cancer	5.07e-05	0.0007	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—testicular cancer	5.06e-05	0.000699	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—testicular cancer	5.06e-05	0.000699	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—testicular cancer	5.04e-05	0.000697	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—testicular cancer	5.04e-05	0.000697	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—testicular cancer	5e-05	0.000692	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—testicular cancer	4.97e-05	0.000687	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—testicular cancer	4.95e-05	0.000685	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—testicular cancer	4.95e-05	0.000684	CcSEcCtD
Cabazitaxel—Asthenia—Etoposide—testicular cancer	4.94e-05	0.000683	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—testicular cancer	4.94e-05	0.000683	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—testicular cancer	4.93e-05	0.000682	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—testicular cancer	4.93e-05	0.000681	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—testicular cancer	4.91e-05	0.000679	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—testicular cancer	4.9e-05	0.000677	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—testicular cancer	4.89e-05	0.000676	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—testicular cancer	4.88e-05	0.000674	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—testicular cancer	4.86e-05	0.000671	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—testicular cancer	4.8e-05	0.000664	CcSEcCtD
Cabazitaxel—Vomiting—Cisplatin—testicular cancer	4.78e-05	0.000661	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—testicular cancer	4.76e-05	0.000658	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—testicular cancer	4.73e-05	0.000654	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—testicular cancer	4.73e-05	0.000654	CcSEcCtD
Cabazitaxel—Diarrhoea—Etoposide—testicular cancer	4.71e-05	0.000652	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—testicular cancer	4.7e-05	0.00065	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—testicular cancer	4.69e-05	0.000648	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—testicular cancer	4.69e-05	0.000648	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—testicular cancer	4.67e-05	0.000646	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—testicular cancer	4.67e-05	0.000645	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—testicular cancer	4.67e-05	0.000645	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—testicular cancer	4.63e-05	0.00064	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—testicular cancer	4.58e-05	0.000633	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—testicular cancer	4.56e-05	0.000631	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—testicular cancer	4.56e-05	0.00063	CcSEcCtD
Cabazitaxel—Dizziness—Etoposide—testicular cancer	4.56e-05	0.00063	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—testicular cancer	4.55e-05	0.000629	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—testicular cancer	4.54e-05	0.000628	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—testicular cancer	4.54e-05	0.000628	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—testicular cancer	4.53e-05	0.000627	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—testicular cancer	4.53e-05	0.000626	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—testicular cancer	4.51e-05	0.000624	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—testicular cancer	4.49e-05	0.000621	CcSEcCtD
Cabazitaxel—Nausea—Cisplatin—testicular cancer	4.47e-05	0.000617	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—testicular cancer	4.44e-05	0.000614	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—testicular cancer	4.41e-05	0.00061	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—testicular cancer	4.41e-05	0.000609	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—testicular cancer	4.39e-05	0.000607	CcSEcCtD
Cabazitaxel—Vomiting—Etoposide—testicular cancer	4.38e-05	0.000605	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—testicular cancer	4.38e-05	0.000605	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—testicular cancer	4.38e-05	0.000605	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—testicular cancer	4.37e-05	0.000604	CcSEcCtD
Cabazitaxel—Headache—Etoposide—testicular cancer	4.32e-05	0.000597	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—testicular cancer	4.3e-05	0.000595	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—testicular cancer	4.3e-05	0.000595	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—testicular cancer	4.3e-05	0.000595	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—testicular cancer	4.29e-05	0.000593	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	4.27e-05	0.000591	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—testicular cancer	4.27e-05	0.00059	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—testicular cancer	4.25e-05	0.000588	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—testicular cancer	4.25e-05	0.000588	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—testicular cancer	4.24e-05	0.000585	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—testicular cancer	4.23e-05	0.000585	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—testicular cancer	4.21e-05	0.000582	CcSEcCtD
Cabazitaxel—Confusional state—Methotrexate—testicular cancer	4.16e-05	0.000575	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—testicular cancer	4.13e-05	0.000571	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—testicular cancer	4.1e-05	0.000567	CcSEcCtD
Cabazitaxel—Nausea—Etoposide—testicular cancer	4.09e-05	0.000566	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—testicular cancer	4.09e-05	0.000565	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—testicular cancer	4.06e-05	0.000561	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—testicular cancer	4.05e-05	0.000559	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—testicular cancer	4.05e-05	0.000559	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—testicular cancer	4.04e-05	0.000558	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—testicular cancer	4.03e-05	0.000557	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—testicular cancer	4.03e-05	0.000557	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—testicular cancer	4.03e-05	0.000557	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—testicular cancer	4.01e-05	0.000555	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—testicular cancer	4.01e-05	0.000554	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	4e-05	0.000553	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—testicular cancer	3.98e-05	0.00055	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—testicular cancer	3.95e-05	0.000546	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—testicular cancer	3.94e-05	0.000545	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—testicular cancer	3.93e-05	0.000544	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—testicular cancer	3.93e-05	0.000544	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—testicular cancer	3.92e-05	0.000542	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—testicular cancer	3.89e-05	0.000538	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—testicular cancer	3.86e-05	0.000534	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—testicular cancer	3.86e-05	0.000533	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—testicular cancer	3.84e-05	0.00053	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—testicular cancer	3.82e-05	0.000528	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—testicular cancer	3.79e-05	0.000523	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—testicular cancer	3.78e-05	0.000523	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—testicular cancer	3.78e-05	0.000522	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—testicular cancer	3.77e-05	0.000521	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—testicular cancer	3.76e-05	0.00052	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—testicular cancer	3.75e-05	0.000518	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—testicular cancer	3.73e-05	0.000515	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—testicular cancer	3.73e-05	0.000515	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—testicular cancer	3.73e-05	0.000515	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—testicular cancer	3.71e-05	0.000513	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—testicular cancer	3.71e-05	0.000512	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	3.7e-05	0.000512	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—testicular cancer	3.68e-05	0.000509	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—testicular cancer	3.68e-05	0.000509	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—testicular cancer	3.68e-05	0.000509	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—testicular cancer	3.65e-05	0.000504	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—testicular cancer	3.63e-05	0.000502	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—testicular cancer	3.61e-05	0.000499	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—testicular cancer	3.6e-05	0.000498	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—testicular cancer	3.59e-05	0.000496	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—testicular cancer	3.57e-05	0.000494	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—testicular cancer	3.56e-05	0.000492	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—testicular cancer	3.56e-05	0.000492	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—testicular cancer	3.55e-05	0.000491	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—testicular cancer	3.53e-05	0.000488	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—testicular cancer	3.52e-05	0.000486	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—testicular cancer	3.5e-05	0.000484	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—testicular cancer	3.5e-05	0.000484	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—testicular cancer	3.49e-05	0.000482	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—testicular cancer	3.47e-05	0.00048	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—testicular cancer	3.47e-05	0.000479	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—testicular cancer	3.44e-05	0.000476	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—testicular cancer	3.41e-05	0.000471	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—testicular cancer	3.4e-05	0.00047	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—testicular cancer	3.4e-05	0.00047	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—testicular cancer	3.37e-05	0.000466	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—testicular cancer	3.36e-05	0.000464	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—testicular cancer	3.34e-05	0.000462	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—testicular cancer	3.33e-05	0.000461	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—testicular cancer	3.33e-05	0.00046	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—testicular cancer	3.3e-05	0.000456	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—testicular cancer	3.3e-05	0.000456	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—testicular cancer	3.26e-05	0.000451	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—testicular cancer	3.26e-05	0.000451	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—testicular cancer	3.26e-05	0.00045	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—testicular cancer	3.21e-05	0.000443	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—testicular cancer	3.19e-05	0.00044	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—testicular cancer	3.18e-05	0.00044	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—testicular cancer	3.16e-05	0.000436	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—testicular cancer	3.15e-05	0.000435	CcSEcCtD
Cabazitaxel—Decreased appetite—Doxorubicin—testicular cancer	3.11e-05	0.000429	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—testicular cancer	3.08e-05	0.000426	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—testicular cancer	3.08e-05	0.000426	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—testicular cancer	3.06e-05	0.000422	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—testicular cancer	3.06e-05	0.000422	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—testicular cancer	3.05e-05	0.000422	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—testicular cancer	3.05e-05	0.000422	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—testicular cancer	3.04e-05	0.00042	CcSEcCtD
Cabazitaxel—Asthenia—Methotrexate—testicular cancer	2.96e-05	0.000409	CcSEcCtD
Cabazitaxel—Feeling abnormal—Doxorubicin—testicular cancer	2.94e-05	0.000407	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—testicular cancer	2.92e-05	0.000404	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—testicular cancer	2.85e-05	0.000393	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—testicular cancer	2.82e-05	0.00039	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—testicular cancer	2.82e-05	0.00039	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—testicular cancer	2.82e-05	0.00039	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—testicular cancer	2.77e-05	0.000383	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—testicular cancer	2.73e-05	0.000377	CcSEcCtD
Cabazitaxel—Diarrhoea—Epirubicin—testicular cancer	2.64e-05	0.000365	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—testicular cancer	2.63e-05	0.000364	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—testicular cancer	2.62e-05	0.000363	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—testicular cancer	2.59e-05	0.000357	CcSEcCtD
Cabazitaxel—Asthenia—Doxorubicin—testicular cancer	2.56e-05	0.000354	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—testicular cancer	2.55e-05	0.000353	CcSEcCtD
Cabazitaxel—Vomiting—Epirubicin—testicular cancer	2.46e-05	0.000339	CcSEcCtD
Cabazitaxel—Nausea—Methotrexate—testicular cancer	2.45e-05	0.000339	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—testicular cancer	2.44e-05	0.000338	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—testicular cancer	2.42e-05	0.000334	CcSEcCtD
Cabazitaxel—Dizziness—Doxorubicin—testicular cancer	2.36e-05	0.000327	CcSEcCtD
Cabazitaxel—Nausea—Epirubicin—testicular cancer	2.29e-05	0.000317	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—testicular cancer	2.27e-05	0.000314	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—testicular cancer	2.24e-05	0.000309	CcSEcCtD
Cabazitaxel—Nausea—Doxorubicin—testicular cancer	2.12e-05	0.000293	CcSEcCtD
